Home | About us | Editorial Board | Search | Ahead of print | Current Issue | Archives | Instructions | Online submissionContact Us   |  Subscribe   |  Advertise   |  Login  Page layout
Wide layoutNarrow layoutFull screen layout
Lung India Official publication of Indian Chest Society  
  Users Online: 195   Home Print this page  Email this page Small font size Default font size Increase font size
Year : 1988  |  Volume : 6  |  Issue : 4  |  Page : 197-198

An Inexpensive Combination Chemotherapy For Inoperable Lung Cancer

Correspondence Address:
D Behera

Login to access the Email id

Source of Support: None, Conflict of Interest: None

Rights and PermissionsRights and Permissions

Vincristine, cyclophosphamide and methotrexate combination chemotherapy was administered on an outpatient basis to 25 patients of advanced bronchogenic carcinoma. The overall median survival of the patients was 30 weeks, patients of small cell carcinoma had a median survival of 23.5 weeks and it was 25 weeks in cases of patients of non-small cell carcinoma. Eleven patients (44%) survived for six months or more, five patients (20%) survived for one year or more and two patients (8%) survived for two years or more. The drug combination is relatively cheap and had no major side effects.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded101    
    Comments [Add]    

Recommend this journal